To draw a clinical correlation between EZH2 and KRT14 expression, we mined Breast Cancer Yau (2010) dataset from breast cancer patients and observed a high EZH2 and KRT14 mRNA expression exclusively in the basal (TNBC) subtype compared to the other breast cancer subtypes (Fig. 8A, B). This evidence concerns the gene EZH2 and breast carcinoma.